Literature DB >> 21683721

Insulin promotes dendritic spine and synapse formation by the PI3K/Akt/mTOR and Rac1 signaling pathways.

Cheng-Che Lee1, Chiung-Chun Huang, Kuei-Sen Hsu.   

Abstract

Insulin and its receptor are broadly expressed throughout the brain and have been postulated to play a crucial role in synaptic plasticity. Although structural remodeling of dendritic spines is associated with stable expression of synaptic plasticity, the role of insulin receptor (IR) signaling in the establishment and dynamic changes of dendritic spines remains unclear. Here we report that insulin promotes dendritic spine formation in primary cultures of rat hippocampal neurons. Conversely, downregulation of IR signaling using a blocking antibody or short hairpin RNAs (shRNAs) resulted in a decrease in number of dendritic spines and caused a significant reduction in the frequency of miniature excitatory postsynaptic currents (mEPSCs) without affecting the distribution of their amplitudes. Pharmacological blockade of phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) signaling pathway and the small GTPase Rac1 specifically prevented the insulin-induced increase in dendritic spine density. In parallel, genetic ablation of Rac1 expression by lentiviral infection with shRNA abrogated the increase in dendritic spines induced by insulin. More importantly, the increase in dendritic spine density by insulin was accompanied by increasing in presynaptic marker staining density and displayed an increase in mEPSC frequency. Taken together, these results reveal a novel role for IR signaling in the regulation of dendritic spine formation and excitatory synapse development in hippocampal neurons through activation of the PI3K/Akt/mTOR and Rac1 signaling pathways.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21683721     DOI: 10.1016/j.neuropharm.2011.06.003

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  75 in total

1.  Brain Insulin Signaling, Alzheimer Disease Pathology, and Cognitive Function.

Authors:  Zoe Arvanitakis; Hoau-Yan Wang; Ana W Capuano; Amber Khan; Bouchra Taïb; Frederick Anokye-Danso; Julie A Schneider; David A Bennett; Rexford S Ahima; Steven E Arnold
Journal:  Ann Neurol       Date:  2020-07-27       Impact factor: 10.422

2.  Experimental induction of type 2 diabetes in aging-accelerated mice triggered Alzheimer-like pathology and memory deficits.

Authors:  Jogender Mehla; Balwantsinh C Chauhan; Neelima B Chauhan
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 3.  Models and mechanisms for hippocampal dysfunction in obesity and diabetes.

Authors:  A M Stranahan
Journal:  Neuroscience       Date:  2015-04-28       Impact factor: 3.590

4.  PPARgamma agonists rescue increased phosphorylation of FGF14 at S226 in the Tg2576 mouse model of Alzheimer's disease.

Authors:  Wei-Chun J Hsu; Norelle C Wildburger; Sigmund J Haidacher; Miroslav N Nenov; Oluwarotimi Folorunso; Aditya K Singh; Brent C Chesson; Whitney F Franklin; Ibdanelo Cortez; Rovshan G Sadygov; Kelly T Dineley; Jay S Rudra; Giulio Taglialatela; Cheryl F Lichti; Larry Denner; Fernanda Laezza
Journal:  Exp Neurol       Date:  2017-05-15       Impact factor: 5.330

Review 5.  Food for thought: the role of appetitive peptides in age-related cognitive decline.

Authors:  Jim R Fadel; Corinne G Jolivalt; Lawrence P Reagan
Journal:  Ageing Res Rev       Date:  2013-02-13       Impact factor: 10.895

6.  Postsynaptic distribution of IRSp53 in spiny excitatory and inhibitory neurons.

Authors:  Alain C Burette; Haram Park; Richard J Weinberg
Journal:  J Comp Neurol       Date:  2014-06-15       Impact factor: 3.215

7.  Chondroitin sulfate proteoglycans down-regulate spine formation in cortical neurons by targeting tropomyosin-related kinase B (TrkB) protein.

Authors:  Dai Kurihara; Toshihide Yamashita
Journal:  J Biol Chem       Date:  2012-03-02       Impact factor: 5.157

8.  MHC class I limits hippocampal synapse density by inhibiting neuronal insulin receptor signaling.

Authors:  Tracy J Dixon-Salazar; Lawrence Fourgeaud; Carolyn M Tyler; Julianna R Poole; Joseph J Park; Lisa M Boulanger
Journal:  J Neurosci       Date:  2014-08-27       Impact factor: 6.167

9.  Bifenthrin causes transcriptomic alterations in mTOR and ryanodine receptor-dependent signaling and delayed hyperactivity in developing zebrafish (Danio rerio).

Authors:  Daniel F Frank; Galen W Miller; Danielle J Harvey; Susanne M Brander; Juergen Geist; Richard E Connon; Pamela J Lein
Journal:  Aquat Toxicol       Date:  2018-04-18       Impact factor: 4.964

Review 10.  Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums.

Authors:  Steven E Arnold; Zoe Arvanitakis; Shannon L Macauley-Rambach; Aaron M Koenig; Hoau-Yan Wang; Rexford S Ahima; Suzanne Craft; Sam Gandy; Christoph Buettner; Luke E Stoeckel; David M Holtzman; David M Nathan
Journal:  Nat Rev Neurol       Date:  2018-01-29       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.